If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.35
Bid: 30.00
Ask: 30.20
Change: 1.45 (5.02%)
Spread: 0.20 (0.667%)
Open: 28.00
High: 31.05
Low: 28.00
Prev. Close: 28.90
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

18 May 2017 07:00

RNS Number : 4793F
Marston's PLC
18 May 2017
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

18 May 2017

MARSTON'S PLC

Acquisition of Charles Wells Brewing and Beer Business for £55 million

Marston's PLC ("Marston's" or "the Group") today announces that it has agreed to acquire the Charles Wells brewing business from the Charles Wells Group for a cash consideration of £55 million, plus working capital adjustments.

Based in Bedford, Charles Wells Brewing and Beer Business is an established high quality brewing business with a portfolio of more than 30 beers including leading brands such as Bombardier, Young's and McEwan's. In addition, the business has UK distribution rights for the Estrella Damm lager brand and other beers under license including Kirin and Erdinger. As part of this acquisition, we have entered into a long-term exclusive agreement to supply all beer, wine, spirits and minerals to the Charles Wells pub estate. The brewery site, which is freehold, employs around 300 people.

The Charles Wells Brewing and Beer Business acquisition complements the existing Marston's Beer Company strategy:

· Extends our number 1 position in the premium bottled ale and cask ale markets, and enhances our share of the premium canned market.

· Strengthens our presence in London and the South East and presents a platform to expand into Scotland.

· Develops our licensed brands business.

· Expands our production capabilities to include lager brewing and canning, whilst improving production and distribution efficiency.

Furthermore, there is a strong financial rationale for the Charles Wells Brewing and Beer Business acquisition:

· Enterprise value of £55 million equates to 9x current EBITDA before synergies.

· Transaction to be funded through equity placing as announced today (see separate announcement).

· Expected synergies of £4 million to be achieved by financial year 2019.

· ROIC expected to exceed 18% in third full year.

 

Rationale for the Charles Wells acquisition

Marston's Beer Company ("MBC") has deployed a consistent strategy over the last five years to become the UK's leading premium beer business. Today, MBC has an experienced senior team and holds leading market share in both the premium bottled and premium cask ale markets. MBC takes a local approach to its brewing capabilities via its portfolio of five regional breweries located throughout England and has recently extended its focus to licensed brands, including Shipyard, which is now the number 2 Craft Beer in the UK, as well as the Warsteiner, Kruzovice and Kingstone Press brands.

MBC has also successfully enhanced shareholder value through acquisitions, most recently through the £25 million purchase of the Thwaites beer business in 2015. Since acquisition the Thwaites beer brands have performed strongly, delivering synergies in line with expectations and returns well in excess of the Group average.

Charles Wells Brewing and Beer Business presents an excellent opportunity which is consistent with our strategy. With a brand portfolio which will not only increase our ale market share from 11% to 16%, this acquisition will also strengthen our representation in London and the South East, and present an opportunity through the McEwan's brand to expand into Scotland. Charles Wells Brewing and Beer Business also brings with it significant expertise in licensed brands most notably its portfolio includes the growing Estrella Damm lager brand which represents a significant opportunity. From a supply chain perspective, Charles Wells offers lager brewing and canning capacity of scale, activities which are not currently undertaken by Marston's. In addition, the acquisition presents opportunities to further improve efficiencies in brewing, packaging and logistics.

Charles Wells Brewing and Beer Business financial profile

For the financial year ended 30 September 2016, Charles Wells Brewing and Beer Business generated revenues of £92 million, EBITDA of £6 million, operating EBIT of £5 million on a 52 week basis and net tangible assets of £36 million. Marston's estimates it can generate operational improvements similar to those achieved in previous acquisitions and has identified potential costs savings of £4 million by financial year 2019, with the majority being realised in financial year 2018.

Transaction details and timing

Marston's intends to finance the acquisition from the proceeds of an equity placing announced today, which represents 9.9% of Marston's issued share capital.

Completion of the acquisition is expected in June 2017, following completion of the appropriate consultation procedures.

Ralph Findlay, Chief Executive Officer of Marston's PLC, commented:

"We are delighted to have agreed to acquire Charles Wells Brewing and Beer Business. It is a high quality brewing business offering us opportunities to extend our trading area in the South of England and Scotland, and brings a range of well-known and popular brands into our portfolio. We also aim to develop further our range of international licensed brands, and look forward to working with our new overseas partners, including Estrella Damm, Erdinger and Kirin.

The acquisition of Charles Wells Brewing and Beer Business builds on Marston's established brewing prowess and is a further step in our objective to develop the leading premium beer business in the UK market. We have demonstrated our ability to acquire, integrate and develop beer brands evidenced by the success of brands such as Hobgoblin, Wainwright, and Lancaster Bomber. We have also achieved success with international licensed brands including Shipyard, now the 2nd biggest craft beer in the UK on trade."

Justin Phillimore, Chief Executive Officer of Charles Wells Brewery Limited, commented:

 

"We are delighted to have reached an agreement with Marston's to acquire our brewery and become a close trading partner. After a detailed review of our strategy we had decided to re-balance the company more towards retail investment and that meant finding a partner we could work with for the future. There are opportunities for both companies in this deal and we look forward to bringing them to life."

 

   

ENQUIRIES:

 

 

 

 

Marston's PLC

Tel: 020 7457 2020 (today)

01902 329516 (thereafter)

 

Instinctif Partners

Tel: 020 7457 2020

Ralph Findlay

Chief Executive Officer

Justine Warren

 

Andrew Andrea

Chief Financial and

Corporate Development Officer

Matthew Smallwood

 

      

 

Disclaimer

This announcement is not and does not contain an offer of securities for sale or a solicitation of an offer to purchase or subscribe for securities in the United States or any other state or jurisdiction in which it would be unlawful. The securities referred to in this announcement (the "Securities") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from, or a transaction not subject to, registration under the Securities Act.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFSDESIDLID
Date   Source Headline
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.